U.S. market Closed. Opens in 1 day 14 hours 29 minutes

CARA | Cara Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue20.97M41.87M23.03M135.08M19.89M13.47M911.00K86.00K3.80M3.18M11.96M1.19MN/A
Cost of Revenue6.43M7.27M1.55M107.07M113.16MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit14.54M34.60M21.47M28.01M-93.28M13.47MN/AN/AN/AN/AN/AN/AN/A
Operating Expenses136.03M122.14M112.11M129.70M131.56M90.85M60.40M58.49M28.99M21.25M12.20M7.43MN/A
Selling, General & Admin27.65M30.26M29.41M21.75M17.75M15.32M11.79M8.61M7.38M5.82M3.52M2.83M2.41M
Research & Development108.38M91.88M82.70M107.85M113.82M75.53M48.52M49.25M21.22M15.07M8.69M4.60M7.16M
Other Operating Expenses3.59M2.06M642.00K97.00K4.49M2.98M77.00K626.00K392.00K361.00KN/AN/AN/A
Operating Income-121.50M-87.53M-89.08M5.38M-111.68M-77.38M-59.48M-58.40M-25.19M-18.07M-237.00K-6.24M-9.57M
Other Expenses / Income2.98M2.06M642.00K2.33M4.49M2.98M1.16M652.00K101.00K126.00K-3.76M-66.00K-275.00K
Before Tax Income-118.51M-85.47M-88.44M7.72M-107.19M-74.40M-58.33M-57.75M-25.09M-17.95M-3.99M-6.30M-9.84M
Income Tax Expenses91.11K-2.06M-248.00K-691.00K-816.00K-389.00K-204.00K-468.00K-397.00K-201.00K-30.00K-31.00K-35.00K
Net Income-118.51M-83.41M-88.19M8.41M-106.37M-74.01M-58.12M-57.28M-24.69M-17.75M-3.96M-6.27M-9.81M
Interest Expenses604.00K-248.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding54.15M53.65M50.72M47.41M42.67M35.89M31.20M27.28M24.62M20.97M21.84M5.95M6.18M
Diluted Shares Outstanding54.15M53.65M50.72M47.92M42.67M35.89M31.20M27.28M24.62M20.97M21.84M5.95M6.18M
EBITDA-121.24M-87.53M-89.08M5.59M-111.68M-77.38M-57.83M-56.28M-24.25M-17.16M-3.20M-5.28M-8.40M
EBITDA Margin-578.20%-209.08%-386.85%4.14%-561.60%-574.52%-6,348.41%-65,445.35%-637.60%-540.23%-26.78%-443.78%0.00%
EBIT-117.82M-85.72M-88.44M7.72M-107.19M-74.40M-58.33M-57.75M-25.09M-17.95M-3.99M-6.30M-9.84M
EBIT Margin-561.89%-204.75%-384.06%5.71%-539.02%-552.39%-6,402.74%-67,148.84%-659.66%-564.87%-33.38%-529.58%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙